Clinical Trials in Detroit

Showing 18181-18200 of 19,719 trials

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

NCT00003223

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of fenretinide may be an effective way to prevent the development of cancer in patients with neoplasia of the mouth. PURPOSE: Phase II trial to study the effectiveness of fenretinide in preventing cancer in patients who have neoplasia of the mouth.

Head and Neck Cancer

SWOG Cancer Research Network5 participantsStarted Dec 1997

Tucson, Arizona, United States • Tucson, Arizona, United States • Kansas City, Kansas, United States +12 more locations

COMPLETEDPhase 26.7 miles

Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

NCT00752609

The purpose of this study is to determine the efficacy and safety of Peginesatide Injection for the maintenance of anemia in patients with chronic renal failure who are on hemodialysis or do not require dialysis and who were previously treated with Darbepoetin Alfa.

Anemia

Takeda102 participantsStarted Sep 2008

Los Angeles, California, United States • Sacramento, California, United States • San Diego, California, United States +7 more locations

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

Find Trials by Condition in Detroit

CRESTOR Athero Imaging Head to Head IVUS Study

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Ulimorelin Study of Efficacy and Safety (ULISES 007)

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Calfactant for Direct Acute Respiratory Distress Syndrome

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Ulimorelin Study of Efficacy and Safety (ULISES 008)

Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis